Contact Us

Multidrug Resistance


Resistance to tuberculosis (TB) drugs is a formidable obstacle to effective TB care and prevention globally. Multidrug-resistant TB (MDR-TB) is multifactorial and fueled by improper treatment of patients, poor management of supply and quality of drugs, and airborne transmission of bacteria in public places. Case management becomes difficult and the challenge is compounded by catastrophic economic and social costs that patients incur while seeking help and spending on treatments.

Learning Outcomes

By the end of this course, the participant will be able to:

  1. Apply interdisciplinary epidemiology approach to study TB, HIV and malaria drug resistant
  2. Identify factors that influence HIV, TB and malaria drug resistance
  3. Apply strategies for minimizing development of drug resistance
  4. Apply strategies for responding to detection of moderate to high levels of drug resistant HIV, TB and malaria

Course Outline

  1. Basic concepts of drug resistance in TB, HIV and malaria
  2. Global epidemiology of drug resistant TB
  3. Laboratory network for the management of drug-resistance TB, HIV and malaria
  4. Reliability of drug susceptibility testing and proficiency testing
  5. Control strategies of drug resistance TB, HIV and malaria
  6. Rapid diagnosis of drug-resistance TB, HIV and malaria utility and limitation
  7. Challenges for programmatic management of drug resistant TB, HIV and malaria
  8. Strengthening existing relevant programs

Training Delivery Methods

  1. In-class method
  2. Online method
  • Duration: 30 Learning Hours

Accredited By


Participant who complete the stand alone course will be awarded a Certificate of Course Completion.